If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.
This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.
Kogenate FS/Bayer is indicated for the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) for adults, adolescents and children of all ages.
Discover the Power of Jivi
Bayer in Hemophilia Tools & Resources Programs for Your Hemophilia Patients
© 2022 Bayer AG
This website is intended to provide information to an international audience outside the USA and UK
Last updated: June 2022